Tolerance induction in experimental autoimmune encephalomyelitis using non-myeloablative hematopoietic gene therapy with autoantigen

Molecular Therapy

Volumn 17, Issue 5, 2009, Pages 897-905

  Eixarch, Herena ^a   Espejo, Carmen ^b   Gómez, Alba ^a   Mansilla, María José ^b   Castillo, Mireia ^b   Mildner, Alexander ^c   Vidal, Francisco ^d   Gimeno, Ramón ^a   Prinz, Marco ^c   Montalban, Xavier ^b   Barquinero, Jordi ^a  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^b IRHUVH   (Spain)

^c UNIVERSITY OF FREIBURG   (Germany)

^d BANC DE SANG I TEIXITS   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIGEN; INTERLEUKIN 10; INTERLEUKIN 5; MYELIN OLIGODENDROCYTE GLYCOPROTEIN[40-55]; RETROVIRUS VECTOR; UNCLASSIFIED DRUG;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; BONE MARROW TRANSPLANTATION; CELL BASED GENE THERAPY; CHIMERA; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE SEVERITY; DRUG MECHANISM; ENGRAFTMENT; FEMALE; HEMATOPOIETIC CELL; HISTOPATHOLOGY; IMMUNIZATION; IMMUNOLOGICAL TOLERANCE; MOUSE; NONHUMAN; PROTECTION; REGULATORY T LYMPHOCYTE; SPLEEN CELL;

ANIMALIA; MURINAE; MUS;

EID: 67349161855     PISSN: 15250016     EISSN: 15250024     Source Type: Journal    
DOI: 10.1038/mt.2009.42     Document Type: Article

References (48)

1. Bracy, JL, Sachs, DH and Iacomini, J (1998). Inhibition of xenoreactive natural antibody production by retroviral gene therapy. Science 281: 1845-1847.
2. Wekerle, T and Sykes, M (2001). Mixed chimerism and transplantation tolerance. Annu Rev Med 52: 353-370.
3. Emery, DW, Sablinski, T, Shimada, H, Germana, S, Gianello, P, Foley, A et al. (1997). Expression of an allogeneic MHC DRB transgene, through retroviral transduction of bone marrow, induces specific reduction of alloreactivity. Transplantation 64: 1414-1423.
4. Bagley, J, Tian, C, Sachs, DH and Iacomini, J (2002). Induction of T-cell tolerance to an MHC class I alloantigen by gene therapy. Blood 99: 4394-4399.
5. Alderuccio, F, Murphy, K and Toh, BH (2003). Stem cells engineered to express self-antigen to treat autoimmunity. Trends Immunol 24 176-180.
6. Steptoe, RJ, Ritchie, JM and Harrison, LC (2003). Transfer of hematopoietic stem cells encoding autoantigen prevents autoimmune diabetes. J Clin Invest 111: 1357-1363.
7. Xu, B, Haviernik, P, Wolfraim, LA, Bunting, KD and Scott, DW (2006). Bone marrow transplantation combined with gene therapy to induce antigen-specific tolerance and ameliorate EAE. Mol Ther 13: 42-48.
8. Evans, GL and Morgan, RA (1998). Genetic induction of immune tolerance to human clotting factor VIII in a mouse model for hemophilia A. Proc Natl Acad Sci USA 95: 5734-5739.
9. Andersson, G, Denaro, M, Johnson, K, Morgan, P, Sullivan, A, Houser, S et al. (2003). Engraftment of retroviral EGFP-transduced bone marrow in mice prevents rejection of EGFP-transgenic skin grafts. Mol Ther 8: 385-391.
10. Kyewski, B and Klein, L (2006). A central role for central tolerance. Annu Rev Immunol 24: 571-606.
11. Limon, A, Briones, J, Puig, T, Carmona, M, Fornas, O, Cancelas, JA et al. (1997). High-titer retroviral vectors containing the enhanced green fluorescent protein gene for efficient expression in hematopoietic cells. Blood 90: 3316-3321.
12. + T cells: Analysis using depleting antibodies. J Autoimmun 23: 1-7.
13. + regulatory cells mediate genetic resistance to experimental autoimmune encephalomyelitis. Proc Natl Acad Sci USA 101: 15434-15439.
14. Bagley, J, Bracy, JL, Tian, C, Kang, ES and Iacomini, J (2002). Establishing immunological tolerance through the induction of molecular chimerism. Front Biosci 1: D1331-d1337.
15. Kang, E, Giri, N, Wu, T, Sellers, S, Kirby, M, Hanazono, Y et al. (2001). In vivo persistence of retrovirally transduced murine long-term repopulating cells is not limited by expression of foreign gene products in the fully or minimally myeloablated setting. Hum Gene Ther 12: 1663-1672.
16. Puig, T, Kadar, E, Limon, A, Cancelas, JA, Eixarch, H, Luquin, L et al. (2002). Myeloablation enhances engraftment of transduced murine hematopoietic cells, but does not influence long-term expression of the transgene. Gene Ther 9: 1472-1479.
17. Bischof, F, Wienhold, W, Wirblich, C, Malcherek, G, Zevering, O, Kruisbeek, AM et al. (2001). Specific treatment of autoimmunity with recombinant invariant chains in which CLIP is replaced by self-epitopes. Proc Natl Acad Sci USA 98: 12168-12173.
18. Brocker, T, Riedinger, M and Karjalainen, K (1997). Targeted expression of major histocompatibility complex (MHC) class II molecules demonstrates that dendritic cells can induce negative but not positive selection of thymocytes in vivo. J Exp Med 185: 541-550.
19. Kang, ES and Iacomini, J (2002). Induction of central deletional T cell tolerance by gene therapy. J Immunol 169: 1930-1935.
20. Forman, D, Kang, ES, Tian, C, Paez-Cortez, J and Iacomini, J (2006). Induction of alloreactive CD4 T cell tolerance in molecular chimeras: A possible role for regulatory T cells. J Immunol 176: 3410-3416.
21. Chan, J, Clements, W, Field, J, Nasa, Z, Lock, P, Yap, F et al. (2006). Transplantation of bone marrow genetically engineered to express proinsulin II protects against autoimmune insulitis in NOD mice. J Gene Med 8: 1281-1290.
22. Marta, CB, Oliver, AR, Sweet, RA, Pfeiffer, SE and Ruddle, NH (2005). Pathogenic myelin oligodendrocyte glycoprotein antibodies recognize glycosylated epitopes and perturb oligodendrocyte physiology. Proc Natl Acad Sci USA 102: 13992-13997.
23. Zhou, D, Srivastava, R, Nessler, S, Grummel, V, Sommer, N, Bruck, W et al. (2006). Identification of a pathogenic antibody response to native myelin oligodendrocyte glycoprotein in multiple sclerosis. Proc Natl Acad Sci USA 103: 19057-19062.
24. Kuhle, J, Pohl, C, Mehling, M, Edan, G, Freedman, MS, Hartung, HP et al. (2007). Lack of association between antimyelin antibodies and progression to multiple sclerosis. N Engl J Med 356: 371-378.
25. Peters, TR, Bodine, DM, McDonagh, KT, Lovett-Racke, A, McFarland, HF, McFarlin, DE et al. (2000). Retrovirus mediated gene transfer of the self antigen MBP into the bone marrow of mice alters resistance to experimental autoimmune encephalomyelitis. J Neuroimmunol 103 51-62.
26. Chan, J, Ban, EJ, Chun, KH, Wang, S, Backstrom, BT, Bernard, CC et al (2008). Transplantation of bone marrow transduced to express self-antigen establishes deletional tolerance and permanently remits autoimmune disease. J Immunol 181: 7571-7580.
27. Chen, CC, Rivera, A, Ron, N, Dougherty, JP and Ron, Y (2001). A gene therapy approach for treating T-cell-mediated autoimmune diseases. Blood 97: 886-894.
28. Chen, CC, Rivera, A, Dougherty, JP and Ron, Y (2004). Complete protection from relapsing experimental autoimmune encephalomyelitis induced by syngeneic B cells expressing the autoantigen. Blood 103: 4616-4618.
29. Roncarolo, MG and Levings, MK (2000). The role of different subsets of T regulatory cells in controlling autoimmunity. Curr Opin Immunol 12: 676-683.
30. + and type 1 regulatory T cells. Curr Top Microbiol Immunol 293: 303-326.
31. + T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature 389: 737-742.
32. Martinez-Forero, I, Garcia-Munoz, R, Martinez-Pasamar, S, Inoges, S, Lopez-Diaz de Cerio, A, Palacios, R et al. (2008). IL-10 suppressor activity and ex vivo Tr1 cell function are impaired in multiple sclerosis. Eur J Immunol 38: 576-586.
33. Kennedy, MK, Torrance, DS, Picha, KS and Mohler, KM (1992). Analysis of cytokine mRNA expression in the central nervous system of mice with experimental autoimmune encephalomyelitis reveals that IL-10 mRNA expression correlates with recovery. J Immunol 149: 2496-2505.
34. Jander, S, Pohl, J, D'Urso, D, Gillen, C and Stoll, G (1998). Time course and cellular localization of interleukin-10 mRNA and protein expression in autoimmune inflammation of the rat central nervous system. Am J Pathol 152: 975-982.
35. + regulatory T cells. Int Immunol 16: 249-256.
36. Anderson, AC, Reddy, J, Nazareno, R, Sobel, RA, Nicholson, LB and Kuchroo, VK (2004). IL-10 plays an important role in the homeostatic regulation of the autoreactive repertoire in naive mice. J Immunol 173: 828-834.
37. Bacchetta, R, Bigler, M, Touraine, JL, Parkman, R, Tovo, PA, Abrams, J et al. (1994). High levels of interleukin 10 production in vivo are associated with tolerance in SCID patients transplanted with HLA mismatched hematopoietic stem cells. J Exp Med 179: 493-502.
38. Roncarolo, MG, Levings, MK and Traversari, C (2001). Differentiation of T regulatory cells by immature dendritic cells. J Exp Med 193 F5-F9.
39. Hawiger, D, Inaba, K, Dorsett, Y, Guo, M, Mahnke, K, Rivera, M et al (2001). Dendritic cells induce peripheral T cell unresponsiveness under steady state conditions in vivo. J Exp Med 194: 769-779.
40. Rutella, S and Lemoli, RM (2004). Regulatory T cells and tolerogenic dendritic cells: From basic biology to clinical applications. Immunol Lett 94: 11-26.
41. Menges, M, Rossner, S, Voigtlander, C, Schindler, H, Kukutsch, NA, Bogdan, C et al. (2002). Repetitive injections of dendritic cells matured with tumor necrosis factor α induce antigen-specific protection of mice from autoimmunity. J Exp Med 195: 15-21.
42. El-Amine, M, Melo, M, Kang, Y, Nguyen, H, Qian, J and Scott, DW (2000). Mechanisms of tolerance induction by a gene-transferred peptide-IgG fusion protein expressed in B lineage cells. J Immunol 165: 5631-5636.
43. + myeloid progenitor cells that differentiate in vivo into resting dendritic cells. Diabetes 54: 434-442.
44. + dendritic cells play an important role in intravenous tolerance and the suppression of experimental autoimmune encephalomyelitis. J Immunol 181: 2483-2493.
45. Tian, C, Yuan, X, Bagley, J, Blazar, BR, Sayegh, MH and Iacomini, J (2008). Induction of transplantation tolerance by combining non-myeloablative conditioning with delivery of alloantigen by T cells. Clin Immunol 127: 130-137.
46. Espejo, C, Carrasco, J, Hidalgo, J, Penkowa, M, Garcia, A, Saez-Torres, I et al. (2001). Differential expression of metallothioneins in the CNS of mice with experimental autoimmune encephalomyelitis. Neuroscience 105: 1055-1065.
47. Prinz, M, Garbe, F, Schmidt, H, Mildner, A, Gutcher, I, Wolter, K et al. (2006). Innate immunity mediated by TLR9 modulates pathogenicity in an animal model of multiple sclerosis. J Clin Invest 116: 456-464.
48. van Loo, G, De Lorenzi, R, Schmidt, H, Huth, M, Mildner, A, Schmidt-Supprian, M et al. (2006). Inhibition of transcription factor NF-κB in the central nervous system ameliorates autoimmune encephalomyelitis in mice. Nat Immunol 7: 954-961.